Late effects of treatment for Wilms tumor

Pediatric Hematology and Oncology

Volumn 26, Issue 6, 2009, Pages 407-413

  Wright, Karen D ^a,b   Green, Daniel M ^a   Daw, Najat C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Late effects; Nephroblastoma; Wilms tumor

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN;

ABDOMINAL RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; HUMAN; INFERTILITY; KIDNEY DYSFUNCTION; MUSCULOSKELETAL DISEASE; NEPHROBLASTOMA; REVIEW; SECOND CANCER; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HEART DISEASES; HUMANS; KIDNEY NEOPLASMS; MUSCULOSKELETAL DISEASES; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; REPRODUCTION; WILMS TUMOR;

EID: 68649109139     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010903019344     Document Type: Review

References (47)

1. Gommersall LM, Arya M, Mushtaq I, et al. Current challenges in Wilms' tumor management. Nat Clin Pract Oncol. 2005;2:298-304. (Pubitemid 40903174)
2. Goorin AM, Chauvenet AR, Perez-Atayde AR, et al. Initial congestive heart failure six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr. 1990;116:144-147.
3. Pritchard-Jones K, Pritchard J. Success of clinical trials in childhood Wilms' tumours around the world. Lancet. 2004;364:1468-1470. (Pubitemid 39410404)
4. Kim S, Chung DH. Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg Clin North Am. 2006;86:469-487.
5. Breslow N, Olshan A, Beckwith JB, et al. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993;21:172-181.
6. Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol. 2004;8:1366-1372.
7. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-3172. (Pubitemid 32591432)
8. Curry HL, Parkes SE, Powell JE, et al. Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer. 2006;42:501-508.
9. Bailey S, Roberts A, Brock C, et al. Nephrotoxicity in survivors of Wilms' tumours in the North of England. Br J Cancer. 2002;87:1092-1098. (Pubitemid 35418103)
10. Oliver JH, Gluck G, Gledhill RB, et al. Musculoskeletal deformities following treatment of Wilms' tumor. Can Med Assoc J. 1978;119:459-464. (Pubitemid 9018616)
11. Shalet SM, Gibson B, Swindell R, et al. Effect of spinal irradiation on growth. Arch Dis Child. 1987;62:461-464.
12. Makiprnaa A. Spinal deformity induced by radiotherapy for solid tumors in childhood: a long term study. Eur J Pediatr. 1993;152:197-200.
13. Wallace WH, Shalet SM, Morris-Jones PH, et al. Effect of abdominal irradiation on growth in boys treated for Wilms' tumor. Med Pediatr Oncol. 1990;18:441-446.
14. Steinherz LJ, Steinherz G, Tan CJ, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672-1677.
15. Marx M. A multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP9/GPOH and SIOP93-01/GPOH. Med Pediatr Oncol. 2002;39:18-24. (Pubitemid 34556430)
16. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2001;19:1926-1934. (Pubitemid 32702536)
17. Green DM, Gregoriev YA, Nan B, et al. Correction to "Congestive heart failure after treatment for Wilms' tumor." J Clin Oncol. 2003;21:2447-2448.
18. Sorensen K, Levitt G, Sebag-Montefiore D, et al. Cardiac function in Wilms' tumor survivors. J Clin Oncol. 1995;13:1546-1556.
19. Levitt G, Bunch K, Rogers CA, et al. Cardiac transplantation in childhood cancer survivors in Great Britain. Eur J Cancer. 1996;32A:826-830. (Pubitemid 26178532)
20. Sorensen K, Levitt GA, Bull C, et al. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer. 2003;97:1991-1998. (Pubitemid 36397277)
21. Pein F, Sakiroglu O, Dahan M, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91:37-44. (Pubitemid 39013042)
22. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989;43:399-402.
23. Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000;11:161-166. (Pubitemid 30112016)
24. Green DM, Fine WE, Li FP. Offspring of patients treated for unilateral Wilms tumor in childhood. Cancer. 1982;49:2285-2288.
25. Li FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms tumor. JAMA. 1987;257:216-219. (Pubitemid 17207834)
26. Wallace WH, Shalet SM, Crowne EC, et al. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol. 1989;1:75-79.
27. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obset Gynecol. 2002;187:1070-1080. (Pubitemid 35178413)
28. Nussbaum Blask AR, Nicholson HS, Markle BM, et al. Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms' tumor treated with radiotherapy. Am J Roentgenol. 1999;172:759-763.
29. Larsen EC, Schmiegelow K, Rechnitzer C, et al. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand. 2004;83:96-102. (Pubitemid 38121736)
30. Bath LE, Critchley HO, Chambers SE, et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol. 1999;106:1265-1272.
31. Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;20:1453-1461. (Pubitemid 44605590)
32. Byrne J, Mulvihill JJ, Connelly RR, et al. Reproductive problems and birth defects in survivors of Wilms tumor and their relatives. Med Pediatr Oncol. 1988;16:233-240. (Pubitemid 18242234)
33. Green DM, Peabody EM, Nan B, et al. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2002;20:2506-2513. (Pubitemid 34525737)
34. Nicholson HS, Blask AN, Markel BM, et al. Uterine anomalies in Wilms' tumor survivors. Cancer. 1996;78:887-891.
35. Byrne J, Nicholson HS. Excess risk for Mullerian duct anomalies in girls with Wilms tumor. Med Pediatr Oncol. 2002;38:258-259. (Pubitemid 34258418)
36. Blatt J. Pregnancy outcomes in long-term survivors of childhood cancer. Med Pediatr Oncol. 1999;33:29-33. (Pubitemid 29318661)
37. Breslow NE, Collins AJ, Ritchey ML, et al. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005;174:1972-1975.
38. Bardi E, Olah AV, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer. 2004;43:668-673. (Pubitemid 39411224)
39. Daw NC, Gregorik D, Rodman J, et al. Renal function after ifosfamide, carboplatin, and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour. Eur J Cancer. 2009;45:99-106
40. Ritchey ML. Renal sparing surgery for Wilms tumor. J Urol. 2005;174:1172-1173. (Pubitemid 41318672)
41. Breslow NE, Takashima JR, Whitton JA, et al. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1995;13:1851-1859.
42. Carli M, Frascella E, Tournade MF, et al. Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Med Pediatr Oncol. 1997;29:239-244. (Pubitemid 27329121)
43. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996;88:270-278.
44. Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case control study in the 5 Nordic countries. The Nordic Society of Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88:672-678.
45. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2002;93:618-629.
46. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumors among childhood cancer survivors. Br J Cancer. 1987;56:339-347.
47. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-593. (Pubitemid 17126781)